← All organizations
University Hospital, Tours
Academic/HospitalWebsite ↗
Also known as: Centre d’Investigation Clinique 1415 | Centre Oncologie Radiothérapie 37 - CORT37 | CHRU DE TOURS | Dr Christophe LENCLUD | Hôpital Bretonneau - University Hospital of Tours | INSERM CIC-P 1415, University Hospital Center of Tours | Tours University Hospital | University Hospital of TOURS | University Hospital of TOURS;INSERM 1246 SPHERE | University Hospital, Tours
Highest phase reached
Phase 4
First clinical trial
Feb 22, 2019Last known activity
Jan 31, 2026
Timeline
1650s
- Jan 1, 1658
University Hospital, Tours— Founded
Drugs by trial phase (32 distinct, 32 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Amyotrophic Lateral Sclerosis
- Cardiomyopathies
- Congenital Abnormalities
- Hemorrhage
- Hyperkalemia
- Lymphangioma
- Lymphatic Abnormalities
- Motor Neuron Disease
- Pneumonia
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Sclerosis
- Signs and Symptoms, Respiratory
- Subarachnoid Hemorrhage
- Vascular Malformations
- Ventricular Dysfunction, Left
Recent trials (38)
- NCT07246265Lead sponsorN/AJan 31, 2026
- NCT06892951Lead sponsorPhase 1/Phase 2Jun 30, 2025
- NCT06821126OfficialPhase 1/Phase 2May 31, 2025
- NCT06263816OfficialPhase 3Nov 15, 2024
- NCT06549231Lead sponsorPhase 3Nov 15, 2024
- NCT06263816Lead sponsorPhase 3Nov 15, 2024
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT06642844Lead sponsorPhase 3Oct 30, 2024
- NCT06508437Lead sponsorPhase 4Sep 25, 2024
- NCT06430489Lead sponsorPhase 2Jun 30, 2024
- NCT06382389Lead sponsorPhase 2Jun 30, 2024
- NCT06349798Lead sponsorPhase 3Apr 30, 2024
- NCT05916963Lead sponsorPhase 3Dec 15, 2023
- NCT05385432Lead sponsorPhase 4Jan 15, 2023
- NCT05596786Lead sponsorPhase 3Dec 15, 2022
Details
- Founded
- Tours, FR Jan 1, 1658
- Last known activity
- Jan 31, 2026